Biologics & Biotechnology

The purpose of the Biologics and Biotechnology Committee is to monitor 1) new developments in veterinary biologics, 2) regulation of the manufacture, distribution and use of veterinary biologics, and 3) needs of the livestock industries for new biological products. The Committee has the responsibility of keeping abreast and advising USAHA of new biotechnology, products and regulations that may have profound economic implications on animal health. Further, the Committee provides a forum to focus on issues and developments in the field of biotechnology that are designed to provide protection to man, animals and the environment.

Committee Roster

Presentations

2017

2016

CVB Update - Byron Rippke, USDA-APHIS-VS
International Serum Industry Association (ISIA) - Rosemary Versteegen, ISIA
National Animal Disease Center-ARS- Marcus Kehrli, USDA-ARS-NADC

Reports

Resolutions

2014

Resolution 26: Manufacturing of Veterinary Biologicals without Licensure

2010

Resolution 33: UPDATING ANTIQUATED TESTING REQUIREMENTS FOR ANIMALS USED IN THE PRODUCTION OF LICENSED SERUM ANTIBODY PRODUCTS

2008

Resolution 32: Funding for New Facility Operations at the National Centers for Animal Health

2006

Resolution 15: Funding for the USDA—AHPIS—VS Center for Veterinary Biologics

2004

Resolution 13: Importation of Fetal Bovine Serum

Resolution 20: USDA Jurisdiction for Animal Disease Vaccines That Also Have a Public Health Benefit